Vildagliptin: Uses, Interactions, Mechanism of Action - DrugBank …
WEBVildagliptin is a once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. Vildagliptin (LAF237) is an orally active antihyperglycemic agent that selectively inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme.
Galvus: Uses, Side Effects, Benefits/Risks | Drugs.com
WEBVildagliptin is indicated in the treatment of type-2 diabetes mellitus in adults: as monotherapy: in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;
Vildagliptin: View Uses, Side Effects and Medicines | 1mg
WEBNov 23, 2021 · Vildagliptin is an antidiabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and postmeal sugar levels.
Vildagliptin: Uses, Dosage, Side Effects and More - MIMS
WEBVildagliptin: Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes. Our drug directory offers in-depth details on its uses, side effects, and more.
Vildagliptin - Uses, Dosage, Side Effects, Price, Composition - Practo
WEBMar 9, 2022 · Vildagliptin is an antidiabetic medicine used alone or in combination with other medicines to treat type 2 diabetes in adults. It works by increasing the activity of hormones that help maintain your blood sugar levels before or after a meal.
Vildagliptin: A Novel Oral Therapy for Type 2 Diabetes Mellitus
WEBVildagliptin was evaluated in a dose-response study by Ristic et al. [26] assessing regimens of vildagliptin 25 mg twice daily, 25 mg daily, 50 mg daily, and 100 mg daily. Both...
Vildagliptin: A Novel Oral Therapy for Type 2 Diabetes Mellitus - Medscape
WEBOne of the few new diabetes medications that can be administered orally, vildagliptin seems effective at lowering glycosylated hemoglobin, fasting plasma glucose, and prandial glucose levels.
Vildagliptin: a new oral treatment for type 2 diabetes mellitus
WEBAn extensive clinical program involving approximately 22,000 patients and 7000 patient-years of exposure to vildagliptin has shown that the agent is well tolerated and efficacious in improving glycemic control in patients with type 2 diabetes mellitus (T2DM).
Vildagliptin: A Novel Oral Therapy for Type 2 Diabetes Mellitus
WEBVildagliptin has been shown to be relatively safe in clinical trials; however, long-term evaluation of safety data and clinical experience of the effects of DPP4 inhibition are necessary. The...
Vildagliptin: A novel oral therapy for type 2 diabetes mellitus
WEBJun 15, 2007 · Vildagliptin is an agent in a new class of medications called dipeptidyl peptidase IV (DPP4) inhibitors. By inhibiting DPP4, vildagliptin causes an increase in glucagon like peptide-1 (GLP-1), an intestinal hormone that aids in glucose homeostasis and insulin secretion.